"Pfizer (PFE) Beat The Numbers And People Just Yawned," Says Jim Cramer

We recently published 10 Stocks Jim Cramer Discussed Including His Palantir Deep Dive. Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer recently discussed.

Pfizer Inc. (NYSE:PFE) reported its third-quarter earnings report yesterday. The results were a solid bunch of numbers that saw the firm post $16.65 billion in revenue and $0.87 in adjusted earnings per share to beat analyst estimates of $16.58 billion and $0.63. However, even though the firm raised its full-year profit per share guidance to $3 and $3.15 per share from an earlier $2.90 to $3.10, its shares remained muted. Cramer has discussed the sentiment surrounding Pfizer Inc. (NYSE:PFE) on several occasions. He believes that the firm needs to find something major to impress investors. The CNBC TV host has also pointed out that Pfizer Inc. (NYSE:PFE)’s investors appear to be satisfied with its 7% yield. In this appearance, he discussed the firm’s earnings report and its dividend:

“Pfizer beat the numbers and people just yawned. Oh my god the group is so challenged.

“But we’re looking for that big win from Seagen. We never got it. It’s a bond. Pfizer’s a bond, it’s kind of like Shylock, you know, I’ll have my bond, no, I’d rather have my stock.”

While we acknowledge the potential of PFE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.